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Abstract Myosin VI (MVI) is the only known myosin
walking towards minus end of actin ﬁlaments and is
believed to play distinct role(s) than other myosins. We
addressed a role of this unique motor in secretory PC12
cells, derived from rat adrenal medulla pheochromocytoma
using cell lines with reduced MVI synthesis (produced by
means of siRNA). Decrease of MVI expression caused
severe changes in cell size and morphology, and profound
defects in actin cytoskeleton organization and Golgi
structure. Also, signiﬁcant inhibition of cell migration as
well as cell proliferation was observed. Flow cytometric
analysis revealed that MVI-deﬁcient cells were arrested in
G0/G1 phase of the cell cycle but did not undergo
increased senescence as compared with control cells. Also,
neither polyploidy nor aneuploidy were detected. Surpris-
ingly, no signiﬁcant effect on noradrenaline secretion was
observed. These data indicate that in PC12 cells MVI is
involved in cell migration and proliferation but is not
crucial for stimulation-dependent catecholamine release.
Keywords Myosin VI   Cell motility   Catecholamine
secretion   Golgi apparatus   Actin cytoskeleton
Introduction
Highly specialized chromafﬁn cells of adrenal medulla
contain secretory organelles, termed as chromafﬁn gran-
ules, containing catecholamines, nucleotides and several
neuropeptides, which are released upon stimulation of
nicotinic receptors. The granules (diameter of about
200–300 nm) are formed at the Golgi apparatus and are
transported to the cytoplasm where they are stored in two
major pools, the reserve and release-ready ones (Hook and
Metz-Boutigue 2002; Trifaro 2002). Stimulation leads to
translocation of the release-ready pool to the submembrane
area, fusion of granules with the plasma membrane, and
subsequent release of the granule content. The granule
pools are separated by a dense actin ﬁlament barrier that, in
response to cell stimulation, undergoes precisely regulated
depolymerization thus enabling shift of the granules from
the reserve to the release-ready pool, and the secretion
process (Bader et al. 2002). These and other observations
(Giner et al. 2005; Jahn et al. 2003; Lang et al. 2000; Rose
et al. 2003; Rudolf et al. 2003; Sasakawa et al. 2002) con-
ﬁrm engagement of actin-based cytoskeleton and myosins
in granules transport and secretion of granule content.
Several myosin isoforms including myosins IA, IIA, IIB,
VA and VI were detected in chromafﬁn cells (Wagner et al.
1992; Rose et al. 2002; Wu et al. 2002; Rudolf et al. 2003;
Neco et al. 2004; Majewski et al. 2010). Rose et al. (2003)
and Rudolf et al. (2003) demonstrated that myosin VA was
involved in granule translocation towards the plasma
membrane, while lack of functional protein led to a
decrease of noradrenaline release and strong reduction of
granule motility within the actin cortex. Myosin IIB was not
found in association with chromafﬁn granules, however, its
indirect implication in the transport of vesicles and the
activity of the docked granules has been postulated (Rose
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DOI 10.1007/s10974-011-9279-0et al. 2003). We showed that myosin VI (MVI) was ubiq-
uitously expressed in PC12 cells and was associated with
various vesicular structures and organelles, including
chromafﬁn granules and the nucleus (Majewski et al. 2010).
MVI is one of the unconventional myosins. It consists of
a 140-kDa heavy chain containing one IQ motif, to which
calmodulin binds. Its C-terminal tail forms a globular
domain, essential for cargo binding and/or interaction with
binding partners (Sweeney and Houdusse 2007; Altman
et al. 2007; Buss and Kendrick-Jones 2011). The recombi-
nant full-length protein is a monomer but it is not excluded
that in vivo MVI may function as a dimer (Lister et al. 2004;
Noguchi et al. 2009). Numerous observations suggest that
MVI is involved in vesicular transport (Mermall et al. 1994;
Buss et al. 2002). It is postulated that the C-terminal glob-
ular domain binds to membrane-associated proteins (termed
as MVI binding partners), such as Dab2 in small intestine
epithelial cells (Morris et al. 2002), SAP97 in the central
nervous system neurons (Wu et al. 2002), GIPC in retinal
pigment epithelium (Aschenbrenner et al. 2003) or opti-
neurin (Spudich et al. 2007). Also, it was shown that the
positively charged region of the globular tail binds specif-
ically to PIP2-containing liposomes (Spudich et al. 2007).
MVI seems to be a processive motor walking on actin
ﬁlaments; however, unlike other myosins characterized so
far, it moves towards the minus (pointed) end of actin ﬁla-
ments(Wellsetal.1999).Itimpliesthatitmayplaydifferent
role than other myosins engaged in the same processes, for
exampleinintracellular trafﬁcking oforganelles andprotein
complexes. Mutations within the MVI gene lead to deafness
in mice (Snell’s waltzer syndrome) and humans due to dis-
integration of the inner ear hair cells (see Redowicz 2002).
There are also other symptoms in mice such as head tossing
and hyperactivity, and in humans gradually developing
blindness, craniofacial aberrations and hypertrophic
cardiomyopathy. Further studies have revealed that Golgi
morphology was affected and collagen secretion was
reducedinﬁbroblastsderivedfromtheSnell’swaltzermouse
(Warner et al. 2003). Moreover, defects in CFTR (cystic
ﬁbrosis transmembrane conductance regulator) apical
endocytosis and morphology of brush border enterocytes as
well as renal proximal tubular endocytosis were observed
(Ameen and Apodaca 2007; Gotoh et al. 2010). Also, severe
defects were visible in hippocampus and the hippocampal
neurons displayed a signiﬁcant deﬁcit in the stimulation-
induced internalization of glutamate receptors (Osterweil
etal.2005).Moreover,Yanoetal.(2006)havedemonstrated
that MVI in hippocampal neurons is involved in neutro-
transmissiondependentonbrain-derivedneurotrophicfactor
(BDNF) and its receptor (TrkB).
Functional studies and cellular localization indicate that
MVI plays a major role in endocytic trafﬁc pathways as
well as in cell motility (see Sweeney and Houdusse 2007;
Buss and Kendrick-Jones 2008). MVI is localized to
clathrin coated pits/vesicles (Buss et al. 2001), the Golgi
complex (Warner et al. 2003), membrane rufﬂes at the
leading edge (Buss et al. 1998) and pre- and postsynaptic
structures in neurons (Osterweil et al. 2005). It has been
also demonstrated that MVI is directly involved in the AP-
1B-dependent sorting of proteins to the basolateral plasma
membrane in polarized epithelial cells (Au et al. 2007).
The exact role of MVI in endocytosis still needs to be
established as it is not clear whether it works as the
transporting motor or as the anchor linking vesicles and/or
plasma membrane proteins to the actin cytoskeleton,
responsible for maintenance of cytoskeleton compartments
integrity. In addition to its role in membrane trafﬁcking
pathways, results obtained on Drosophila MVI in the ovary
border cells and spermatids (Hicks et al. 1999; Geisbrecht
and Montell 2002) and its localization to membrane rufﬂes
in mammalian ﬁbroblasts (Buss et al. 1998) indicate that
MVI is also essential for cell locomotion. Furthermore,
observations that MVI is overexpressed in the malignant
human ovarian cancer cells and that inhibition of its
expression in the mouse tumor cells with the RNAi signif-
icantly inhibits their invasiveness (Yoshida et al. 2004)
may also conﬁrm its role in cell migration.
In this study, we addressed a role of MVI in PC12 cells
derived from rat pheochromocytoma (adrenal medulla
tumor), which are widely used as a cell model to study
neuronal and endocrine secretion (Martin and Grishanin
2003). The data indicate that MVI is involved in cell
migration and proliferation but is not crucial for cate-
cholamine secretion.
Materials and methods
Cell culture
PC12 cells (American Cell Culture Collection, USA) were
cultured at 37C under 5% CO2 in RPMI 1640 media sup-
plemented with 10% heat-inactivated horse serum and 5%
fetal bovine serum or F12K media supplemented with 15%
heat-inactivated horse serum and 2.5% fetal bovine serum.
siRNA knockdown of MVI
PC12 celllines,inwhich MVIgene expressionwasknocked
down were created using constructs based on pSilencer
2.1-U6 hygro vector (Ambion Inc., USA) with introduced
the following siRNA sequences: (i) for a transient knock-
down (T-MVI) 50-ATCTAAGCTGGCAGTCCAC-30 (corre-
sponding to 1882–1900 nt; Fig. 1a) and (ii) for a stable
knockdown (S-MVI) 50-GAGAGUCAAUUUGUGGCUA-30
(corresponding to 2346–2364 nt, Fig. 1a). siRNA sequences
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using siRNA Target Finder available on line (http://www.
ambion.com/techlib/misc/siRNA_ﬁnder.html). As negative
controls, mock transfected cells or cells transfected with pSi-
lencer vector carrying scrambled shRNA (sc1MVI or sc2MVI)
were used. Scrambled shRNA were designed based on
the original siRNA sequences using on-line GeneScript
tool. The following scrambled sequences were selected: for
sc1MVI50-GCATTGTGGATGAATAGCT-30andforsc2MVI
50-CGCATTGTGGATGAATAGC-30. PC12 cells were trans-
fected using Lipofectamine 2000 (Invitrogen, USA). Stably
transfectedcells(fromtwoindependenttransfections:SA-MVI
and SB-MVI) with reduced levels of MVI expression were
selected based on their resistance to hygromycin. Both T-MVI
and S-MVI cells were examined for MVI gene expression by
the Western blot, and S-MVI cell lines by RT-PCR technique.
To amplify fragments of MVI as well as of GADPH genes
(used as the internal control to normalize gene expression), the
following primers were used: MVI_F 50-GATGGAGCTGCA
CCCTGACA-30,M V I _ R3 0-GCTCTCAATGGCGCTCTGA
AG-50 and GAPDH_F 50-ACCACAGTCCATGCCATC
AC-30, GAPDH_R 30-TCCACCACCCTGTTGCTGTA-50.
Antibodies and ﬂuorescent markers
Rabbit polyclonal antibody directed against amino-acid
residues 1049–1054 of porcine MVI heavy chain, originally
developed by Dr. Tama Hasson, was from Proteus (USA).
Rabbit polyclonal antibody against myosin V (MV) and
monoclonal antibody against b-actin were purchased from
Sigma-Aldrich (USA). Monoclonal antibodies against
Fig. 1 Depletion of MVI by siRNA technique affects morphology of
PC12 cells. a Diagram presenting the location of the regions to which
shRNA oligos were produced to obtain cell lines with transient MVI
knockdown (T-MVI cells) and stable MVI knockdown (S-MVI cells);
b Immunoblot analysis of MVI level in lysates of cells transiently
transfected with pSilencer vector to knockdown MVI gene expression
(T-MVI) as well as lysates of control cells without the vector (mock
control) and the vector containing scrambled shRNA sequence
(sc1MVI), 24, 48, 72 and 96 h after transfection. Lower panel,a
42-kDa band corresponding to actin was stained with Ponceau red on
a nitrocellulose membrane after transfer of the gel with the above
described samples. The quantiﬁcation of MVI content in T-MVI
samples in every time-point was made in reference to control sc1MVI
lysates at the corresponding time-point. c Immunoblot and RT-PCR
analyses of SA-MVI and SB-MVI cells as well as of mock-control
cells and sc2MVI cells. Lower panels, a 42-kDa band detected with
anti-b-actin antibody and an ampliﬁed GAPDH fragment, used as
internal controls. The quantiﬁcation of MVI content in SA-MVI and
SB-MVI samples was made in reference to the control sc2MVI
sample. For b and c, this is as representation of results obtained from
three independent experiments. d Analysis of size of SA-MVI, mock
control and sc2MVI cells. Cells were stained with TRITC-phalloidin
and DAPI, and then cell area was estimated with Leica software; bar
50 lm. The results are presented for 150 cells from each cell type,
where 100% represents the sum of the cells of a given line subjected
to the analysis. Statistical relevance measured with Student’s t test
*P\0.05 and ***P\0.001, respectively. e Scanning electron
microscopy images of examples of SA-MVI as well as mock control
and sc2MVI cells. Bars 5 lm. All other details as described under
‘‘Materials and methods’’ section
c
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123GM130 and TGN38 as well as against dopamine b-hydrox-
ylase (DBH) were from BD Transduction Laboratories
(USA). DAPI (4a, 6-diamidino-2-phenylindole) was from
Vector Laboratories (USA). TRITC-phalloidin as well as
To-Pro3 were from Invitrogen (USA). For immunocyto-
chemistry studies, the following secondary antibodies from
Molecular Probes were used: goat anti-rabbit IgG labeled
with Alexa Fluor 488 dye and goat anti-mouse IgG labeled
with Alexa Fluor 546 dye.
Stimulation of secretion
To induce noradrenaline (NA) secretion, PC12 cells were
cultured as described above and stimulated essentially
according to Trifaro ´ and Lee (1980) and Vitale et al.
(1992). Brieﬂy, cells were washed with Locke’s solution
containing 2.6 mM KCl, 154 mM NaCl, 2.2 mM CaCl2,
0.5 mM KH2PO4, 1.25 mM K2HPO4, 1.2 mM MgCl2 and
10 mM glucose. Then, they were incubated for 5–10 min
in Locke’s solution with elevated K
? concentration
(56 mM KCl, 103.6 mM NaCl, 2.2 mM CaCl2, 0.5 mM
KH2PO4, 1.25 mM K2HPO4, 1.2 mM MgCl2,1 0 m M
glucose) to stimulate the secretion, or in calcium-free
Locke’s solution (154 mM NaCl, 2.6 mM KCl, 0.5 mM
KH2PO4, 1.25 mM K2HPO4, 1.2 mM MgCl2 and 10 mM
glucose) to block the secretion. The cells were further
processed for immunocytochemistry, electron microscopy
or catecholamine release assay.
Cell lysates
Cells were washed with ice-cold PBS, collected at 800 x g
and homogenized in a Teﬂon homogenizer in a buffer
[50 mM Tris–HCl pH 8.0; 150 mM NaCl, 0.1% TritonX-
100, 2 mM EGTA, 1 mM DTT, 1 mM PMSF and Com-
plete protease inhibitor cocktail (Roche Diagnostics
GmbH, Germany)]. Lysates were subjected to the SDS-
PAGE followed by the immunoblot analysis of the pres-
ence of MVI using anti-MVI and anti-bactin antibodies.
Protein concentration was determined using the standard
Bradford method.
Immunoblotting
PC12 cell lysates were separated using 10% polyacryl-
amide SDS gels and then transferred to a nitrocellulose
membrane. After transfer, the membrane was blocked for
1 h at room temperature in TBS containing 5% non-fat
milk powder and 0.2% Triton X-100 followed by 1-h
incubation with appropriate dilutions of different antibod-
ies described above. The primary antibodies were detected
using a 1:10000 dilutions of anti-rabbit or 1:5000 anti-
mouse secondary antibodies conjugated with horse radish
peroxidase; the reaction was developed using the ECL
method as described by the manufacturer (Pierce, USA).
Usually 10–20 lg of protein was loaded and 42-kDa band
corresponding to actin stained either with Coomassie bril-
liant blue in the gels or with Ponceau red on the nitrocel-
lulose, or detetected with anti-b-actin antibody served as
the internal loading control.
Densitometric analysis
The content of MVI or RT-PCR product corresponding to
MVI cDNA fragment was estimated by densitometric
analysis of immunoblots and agarose gels, respectively.
The membranes or gels were photographed using G:Box
system from SynGene (Cambridge, Great Britain) equip-
ped with GeneSnap and GeneTools software.
Immunolocalization studies
Distribution of MVI and other marker proteins in PC12
cells was examined by indirect immunocytochemistry
before or after stimulation with 56 mM KCl. Cells were
ﬁxed in 4% paraformaldehyde for 20 min and then per-
meabilized with 0.1% Triton X-100 for 5 min. The ﬁxed
specimens were thoroughly washed in phosphate-buffered
saline (PBS) and treated for 1 h with 3% solution of bovine
serum albumin (BSA) in PBS. Cells were incubated over-
night at 4C with anti MVI antibodies at a dilution of 1:50.
This was followed by incubation with Alexa 488-conju-
gated secondary anti-rabbit antibodies at a dilution of
1:1000 for 1 h. For simultaneous assessment of distribution
of other proteins, cells were also incubated with appro-
priate dilutions of the above described antibodies, and
then with Alexa 546-conjugated secondary antibodies. The
specimens were visualized using Leica TCS SP2 or Leica
TCS SP5 spectral confocal microscopes.
Scanning electron microscopy (SEM)
For SEM, cells were ﬁxed in 2.5% glutaraldehyde with
0.1% tannic acid in PBS for 1 h, dehydrated through gra-
ded series of ethanol and acetone, dried by CO2 critical
point method and then coated with a thin layer of carbon
and gold. Samples were examined using Jeol JEM-1200EX
electron microscope with an ASID 19 scanning attachment,
operating at 80 kV.
Transmission electron microscopy (TEM)
Cells were ﬁxed in 0.5% glutaraldehyde with 2.5% para-
formaldehyde in 0.2 M phosphate buffer pH 7.2 for 1 h,
dehydrated through graded series of ethanol and embedded
in LR White resin from Fluka (Switzerland). The samples
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crotome. Ultrathin sections were placed on copper grids
and analyzed under a JEOL JEM-1200EX electron
microscope.
Evaluating cell size and proliferation
After 48 h S-MVI, sc2MVI and mock control PC12 cells
were ﬁxed in 4% paraformaldehyde for 20 min and washed
twice with PBS. Next, they were quenched for 30 min in
PBS with 50 mM NH4Cl and incubated for 1 h in blocking
solution (2% horse serum in PBS/0.02% Triton X-100). To
visualize actin cytoskeleton and nuclei, the cells were
stained for 15 min with 50 mg/ml of TRITC-conjugated
phalloidin (Sigma, USA) and To-Pro3 (Invitrogen, USA) in
PBS, and next washed three times with PBS before
mounting. Immunoﬂuorescent images were prepared using
laser scanning confocal microscope Leica TCS SP2 (Leica
Microsystems). Next, at least 150 single cells for each the
cell type were outlined using the ImageJ software and their
area was calculated, using the same software. Statistical
analysis was performed using Student’s t test.
For the proliferation assay, cells were grown up to 96 h
and counted either in the Neubauer chamber or using hand-
held automated cell counter (Scepter 2.0, Millipore, USA).
They were plated onto six-well dishes at the density of
1 9 10
5 cells per well. Next after 72 and 96 h, cells were
collected by trypsinization, counted and the population
doubling time (DT) was calculated. To estimate cell via-
bility, either trypan blue standard technique or ﬂow
cytometry cell viability assay using propidium iodide were
employed. Statistical analysis was performed using Stu-
dent’s t test.
Catecholamine release
Secretion assays were performed according to Francis et al.
(2002) with modiﬁcations. PC12 cells with MVI knock-
down (T-MVI) and control sc1MVI were cultured for 72 h
on 24-well plates in culture medium with 100 nM
[
3H]noradrenaline ([
3H]NA; 54.6 Ci/mmol, Perkin Elmer,
Boston, USA) and 100 nM nonradioactive noradrenaline
(NA) for 10 min at 37C, exhaustively washed with
Locke’s solution and then incubated for 7 min at 37Ci n
Locke’s solution with elevated K
? concentration to stim-
ulate the secretion, or in calcium-free Locke’s solution to
block the secretion. Next, the cells were washed again with
Locke’s solution and lysed in 5% SDS. All samples: media,
solutions as well as cell lysates were collected and the
amount of [
3H]NA in the samples was determined by
scintillation counter (Beckman LS 6500, USA) to calculate
the NA release and uptake. The ratios of NA release to
uptake in control and transfected cells were quantiﬁed in
four independent experiments performed in duplicates.
Wound healing assay
A scratch was made with a 0.2 ml pipette tip across a
monolayer of SA-MVI and SB-MVI cells as well as
sc2MVI and mock control PC12 cells, which were cultured
on 60-mm dish. Cell debris was washed off and a new
portion of culture medium was added. Images of ﬁve dif-
ferent areas along the artiﬁcial wound were made after 24
and 48 h culture, and the number of cells detected in the
scratch area was counted. Statistical analysis was per-
formed using Student’s t test.
Migration assay
To assess the effect of MVI knockdown on migration of
PC12 cells, 5000 of SA-MVI cells as well as control cells:
sc2MVI and mock control were plated on 8-well cham-
bered coverglass (Nunc) and cultured for 24 h. Cells were
ﬁlmed in bright ﬁeld for 12 h with 10 min time lapse using
Leica TCS SP5 confocal microscope with 109 objective
and a temperature-controlled live-cell imaging chamber. At
least 20 cells from each cell type were tracked using
MetaMorph software in each of three independent experi-
ments. Statistical analysis was performed using Student’s
t test.
Detection of senescence-associated b-galactosidase
SA-b-galactosidase (SA-b-gal) activity was measured
using ﬂow cytometry, as described by Kurz et al. (2000).
Brieﬂy, SA-MVI PC12 cells and the control ones (sc2MVI
and mock control) were incubated with 33 mM non-ﬂuo-
rescent SA-b-gal substrate (C12FDG; Invitrogen, Paisley,
UK) and after exhaustive wash the ﬂuorescence corre-
sponding to the product SA-b-galactosidase was immedi-
ately measured by ﬂow cytometry using CellQuest
Software; 10 000 events were counted for each sample
(FACS Calibur, Becton–Dickinson).
DNA content analysis and cell cycle analysis
For DNA content analysis, the culture medium was dis-
carded and SA-MVI and control PC12 cells were collected
by trypsinization, ﬁxed in 70% ethanol overnight at 4C and
then stained with PI solution (3.8 mM sodium citrate,
50 mg/ml RNAse A and 500 lg/ml propidium iodide in
PBS).DNAcontentwasdeterminedbyﬂowcytometryusing
CellQuest Software; 10.000 events were counted for each
sample (FACSCalibur, Becton–Dickinson). The percentage
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ModFit software (Becton–Dickinson, USA).
Results
Analysis of PC12 cell lines with MVI expression
knockdown
We have previously shown that in PC12 cells MVI is
ubiquitously expressed and is associated with various
vesicular structures, including synaptic vesicles and chro-
mafﬁn granules (Majewski et al. 2010).
To characterize a role of MVI in PC12 cells, siRNA
technique was employed to knockdown its expression and
to produce cell lines: one with transiently (T-MVI) and
two independent with stably (SA-MVI and SB-MVI)
knocked down MVI expression (Fig. 1a). Figure 1b
demonstrates Western blot analysis of T-MVI cells
lysates, in comparison with mock transfected cells (con-
trol), and cells transfected with scrambled MVI sequence
(sc1MVI). MVI level in T-MVI cells was decreased by
about 70–80% 96 h after the transfection in comparison
with control cells. Similar inhibition was achieved for
SA-MVI and SB-MVI cell lines in regard to sc2MVI
control cells (Fig. 1c). Protein level was decreased by
about 80% for SA-MVI and 95% for SB-MVI, and RNA
level was decreased by about 60% and 80%, respectively.
Both stably transfected cell lines exhibited nearly identi-
cal properties therefore in most of the cases only one of
them is presented herein.
Analysis of SA-MVI cell line by means of the ﬂuores-
cence and scanning electron microscopy revealed the pres-
ence of signiﬁcant pools of small and large cells, contrary to
mock control cells and sc2MVI cells (Fig. 1d, e). Quantiﬁ-
cation of the cell area revealed that for mock control cells it
was 825 ± 403 lm
2, for sc2MVI cells—1009 ± 550 lm
2
while for SA-MVI cells—1416 ± 2078 lm
2. As presented
in Fig. 1d, there was about twice as much of large (size
[1500 lm
2) and small cells (size\400 lm
2) in SA-MVI
cell line in comparison with mock and sc2MVI control cells.
The morphology of SA-MVI cells, especially of those large
ones, was also changed as presented in Fig. 1e. The cells
became more ﬂat, less polarized, and seemed to form mul-
tiple thin ﬁlopodia-like processes.
Effect of myosin VI depletion on organization of Golgi
apparatus and actin cytoskeleton
Warner et al. (2003) showed for the ﬁrst time that in
ﬁbroblasts derived from Snell’s waltzer mice lacking MVI,
profound changes in Golgi organization were observed. We
also observed severe alterations in Golgi morphology in
both T-MVI (Fig. 2a) and both S-MVI cell lines (Fig. 2b,
presenting SA-MVI cells). To visualize the Golgi com-
plexes in SA-MVI cells, antibodies against two Golgi
protein markers were used, GM130 and TGN38. While in
both types of control cells Golgi apparatus was concen-
trated in well organized compact structures adjacent to a
small fraction of the nucleus circumference, in MVI-deﬁ-
cient, T-MVI and SA-MVI cells Golgi complexes were
fragmented and elongated, often forming a semi-coat
around the nucleus (Fig. 2a, arrowheads and b). These data
suggest that also in PC12 cells MVI is engaged in Golgi
organization.
MVI is believed to be involved in the regulation of actin
cytoskeleton organization (Hertzano et al. 2008; Chibalina
et al. 2009, 2010; Jbireal et al. 2010; Mangold et al. 2011).
We tested whether MVI depletion affected organization of
actin cytoskeleton; as e.g. in a large S-MVI cell shown in
Fig. 2b. In control cells, ﬁlamentous actin localized in the
cell cortex and few stress ﬁbers were visible. In MVI
depleted cells (here shown SA-MVI cells), actin was seen
as the thick cortical layer and in numerous ﬁlopodial
structures. It was also present in the perinuclear area and
big spots around large vacuolar structures. These data
suggest that MVI is engaged in cytoskeleton organization
also in PC12 cells.
Effect of MVI depletion on PC12 cells migration
Changes in actin cytoskeleton are known to affect cell
motility. Therefore we decided to test whether depletion of
MVI affected S-MVI cells migration (Fig. 3a–c).
Using wound healing assay it was shown that the
number of cells migrating into the wound area after 24 h
was over thrice smaller for SA-MVI and SB-MVI cells in
comparison with the control cells (21 ± 2 cells in the
scratch zone for SA-MVI and 19 ± 2 for SB-MVI vs.
65 ± 3 cells for mock control and 55 ± 3 for sc2MVI).
Similar observation was made after 48 h (59 ± 3 cells for
SA-MVI and 45 ± 4 for SB-MVI vs. 158 ± 5 for mock
control and 154 ± 6 for sc2MVI).
These results indicate that MVI may be involved in
PC12 cells motility, thus conﬁrming observations of
Fig. 2 Depletion of MVI affects Golgi and cytoskeleton organization.
MVI distribution in T-MVI 72 h after transfection (a) and SA-MVI
cells (b) as well as in control cells (mock control and sc1MVI or
sc2MVI)wasvisualizedwithanti-porcineMVIantibody(green).Golgi
structureswerestainedwithanti-GM130orTGN38antibodies(inred),
microﬁlaments with TRITC-phalloidin (red) and nuclei with ToPro3
(blue). In a, arrowheads point to the most altered Golgi complexes.
These are the 0.8-lm images of the cell center attained with Leica TCS
SP2orSP5spectralconfocalmicroscopesequippedwithHCXPLAPO
63x/1.25-0.75 Oil Cs objectives. Other details as described under
‘‘Materials and methods’’ section. Bars 10 lm
c
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123Geisbrecht and Montell (2002) and Yoshida et al. (2004),
who demonstrated that MVI was engaged in the migration
of Drosophila border cells and malignant human ovarian
cancer cells, respectively. It is known that wound healing is
dependent not only on cell migration but also on cell
proliferation, especially for longer incubation times.
Therefore, the time lapse technique with tracking of indi-
vidual cells was applied to assess migration of the living
cells (Fig. 3c). Depletion of MVI caused statistically
signiﬁcant changes in migration rate (0.29 ± 0.07 lm/min
for SA-MVI cells) in regard to mock control (0.40 ±
16 lm/min) and sc2MVI (0.39 ± 15 lm/min) cells thus
conﬁrming involvement of this motor protein in migration
of PC12 cells.
To test whether MVI depletion affects also proliferation
of PC12 cells, a deﬁned number (1 9 10
5) of both control
and SA-MVI and SB-MVI cells was cultured for 96 h and
at the given time intervals aliquots were taken and the cells
were counted (Fig. 3d). As seen on the graph, depletion of
MVI caused a signiﬁcant decrease in cell number in both
S-MVI cell lines. While in both types of control cells after
96 h it was about 10 9 10
6 cells, in S-MVI cells it was
about 5 9 10
6. Also, the doubling time (time required to
double cell number in a culture) was almost twice longer
for the S-MVI cells: for both types of control cells it was
25.4 ± 1.2 h for mock control and 27.2 ± 1.1 h for
sc2MVI while it was 44.4 ± 5.2 h for SA-MVI and
45.3 ± 3.6 h for SB-MVI cells. These values were not
affected by PC12 cell viability as it was nearly the same for
all tested cell types (96–99%) as shown in Fig. 3e.
These data indicate that in PC12 cells MVI functions not
only in cell locomotion but may be also engaged in regu-
lation of cell proliferation.
Effect of MVI depletion on PC12 cell cycle
The observed differences in cell proliferation indicate that
MVI may be involved in regulation of cell division. To
address this, we performed quantiﬁcation of the DNA
content in both types of control cells and S-MVI cells by
means of ﬂow cytometry (Fig. 4).
Analysis of the DNA content revealed there were no
major differences between S-MVI and control cells, neither
aneuploidy nor polyploidy (Fig. 4a). However, we found
that MVI depleted cells were arrested in G0/G1 phase of
the cell cycle, as the percentage of SA-MVI cells entering
G2/M phase was about four times smaller than in control
cells (5.75% for SA-MVI vs. 25.22% for mock control and
18.64 for sc2MVI).
Noteworthy, the observed changes in cell proliferation,
cell size and cell cycle arrest in G0/G1 phase are also
characteristic for the senescent cells. Another feature of
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123Fig. 3 Depletion of MVI affects migration and proliferation of PC12
cells. a Wound healing assay of SA-MVI and SB-MVI cells as well as
mock control and sc2MVI cells. Images of the same scratch areas were
taken after 24 and 48 h, as indicated. The dashed line represents the
initial scratch and measurement area. These are representative images
from ﬁve independent experiments. b Quantiﬁcation of cell number
fromexperimentsdescribedin‘‘a’’.Thevaluesarethemeans(±SD)of
the cells counted in the measurement area. Statistical relevance
measured with Student’s t test is ***P\0.001. c Migration rates of
SA-MVI, sc2MVI and mock control cells assessed with time lapse
technique of living cells and quantiﬁed with Metamorph software. At
least20cellsfromeachlinewereanalyzedineachofthreeindependent
experiments. The values are the means (±SD); statistical relevance
measured with Student’s t test is *P\0.05. d Proliferation test of SA-
MVIand SB-MVI aswell asof controlsc2MVIand mockcontrol cells.
The number of cells in each of the cell culture was counted after 72 and
96 h. The population doubling time (DT) for each of the culture was
calculated based on the data obtained from three independent exper-
iments (n = 3); statistical relevance measured with Student’s t test is
***P\0.001. e Viability test of SA-MVI and SB-MVI as well as of
control sc2MVI and mock transfected cells. Cells were subjected to the
ﬂowcytometricanalysisusingpropidiumiodideafter48,72and96 hof
culture. The values are obtained from two independent experiments;
Other details as described under ‘‘Materials and methods’’ section
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123senescent cells is an increase of SA-b-galactosidase (SA-b-
gal) activity, which can be measured by ﬂow cytometry. To
address whether stable depletion of MVI can promote cell
senescence, the cytometric SA-b-gal activity test was
performed (Fig. 4b). There were no signiﬁcant differences
in the ﬂuorescence corresponding to the SA-b-gal product
between both types of control and SA-MVI cells, thus
indicating that depletion of MVI was not evoking cell
senescence.
MVI depletion does not affect catecholamine secretion
Observation that in PC12 cells depletion of MVI caused
changes in Golgi organization and actin cytoskeleton
organization encouraged us to test whether the depletion
affects catecholamine secretion. The experiment was per-
formed according to the method of Francis et al. (2002)
using radioactive noradrenaline (
3H[NA]) and quantiﬁca-
tion of its uptake and release in samples from control
sc1MVI and T-MVI cells (Fig. 5A). In T-MVI cells
grown for 72 h, upon stimulation with 56 mM KCl
about 10% increase in the ratio of
3H[NA] release:uptake
was observed, when compared with the control sc1MVI
[Fig. 5A(a)]. However, this increase was statistically
insigniﬁcant and most probably associated with the higher
amount of noradrenaline incorporated by the cells with
MVI knockdown [Fig. 5A(b)].
Also, we tested whether 10-min stimulation affected
MVI localization in control cells (Fig. 5B). There were no
substantial changes in its distribution that was in contrast
with MV localization, which after 10 min incubation with
KCl shifted from the cytoplasm to the cell periphery
(Fig. 5B). As expected, upon stimulation the distribution of
dopamine b-hydroxylase (the chromafﬁn granule marker)
shifted towards plasma membrane. The stimulation-
dependent change in the granule localization was further
conﬁrmed by transmission electron microscopy (Fig. 5C,
TEM). Also, scanning electron microscopy revealed that
stimulation evoked noticeable changes in PC12 cells
morphology as the surface of cell body had become more
wrinkled (Fig. 5C, SEM).
Discussion
We have shown herein that MVI is involved in cell
migration and proliferation but not in catecholamine
secretion in neurosecretory PC12 cells. The latter is in
contrast with MV, which was shown in numerous studies to
play an important role in catecholamine release (Rose et al.
2003; Rudolf et al. 2003; Watanabe et al. 2005).
Our observation that depletion of MVI inhibited PC12
cell migration is in line with the previous studies on Dro-
sophila border cells or malignant human ovarian cancer
cells (Geisbrecht and Montell 2002; Yoshida et al. 2004).
The authors pointed at cadherin-dependent mechanism as
the one, in which MVI could be involved in. Our studies
indicate that MVI-dependent regulation of cell migration
might also result from its involvement in regulation of actin
cytoskeleton organization as signiﬁcant changes in actin
cytoskeleton arrangement in MVI-deﬁcient cells were
observed. It is known that several factors such as neuro-
toxin taipoxin or actin-fragmenting protein scinderin
Fig. 4 MVI and the PC12 cell cycle. a Flow cytometric analysis of
cell cycle of SA-MVI, mock transfected and sc2MVI cells. DNA
content was estimated using propidium iodide (left panels) and cell
cycle analysis (right panels) was made with Modtif software (Becton–
Dickinson). These are representative histograms and analyses from
three independent experiments. b SA b-galactosidase activity mea-
surements of SA-MVI and mock transfected and sc2MVI cells. The
bars represent the mean values (±SD) of ﬂuorescence corresponding
to SA b-galactosidase product. The values were obtained from three
independent experiments. Other details as described under ‘‘Materials
and methods’’ section
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123destabilize very dense F-actin rich cortex of PC12 cells
thus enhancing neurotransmitter release (Vitale et al. 1991,
1992; Neco et al. 2003; Dumitrescu Pene et al. 2005). Thus
it is possible that these MVI-associated cytoskeleton rear-
rangements might be responsible for the observed inhibi-
tion of PC12 cell migration.
We have also observed that depletion of MVI affected
PC12 cell proliferation. MVI involvement in the regulation
of cell division was reported for the ﬁrst time by Petritsch
et al. (2003) who demonstrated that in Drosophila neuro-
blasts MVI isoform, Jaguar, was necessary for basal pro-
tein targeting and spindle orientation. Arden et al. (2007)
have shown that in dividing epithelial MDCK cells local-
ization of MVI changed dramatically and inhibition of its
expression by siRNA led to a delay in metaphase pro-
gression and a cytokinesis defect. Using ﬂow cytometry
techniques, we showed that the observed effect of MVI
depletion on PC12 cell proliferation was most probably
Fig. 5 MVI is not crucial for catecholamine secretion. A Inﬂuence of
MVI knockdown on secretion (a) and uptake (b) of noradrenaline
(NA) in T-MVI and control sc1MVI cells. These values (presented as
means ± SD) were calculated based on the radioactive noradrenaline
([
3H[NA]) measurements in the samples, as described in ‘‘Materials
and methods’’. (a) Secretion stimulated with 56 mM KCl is presented
as the ratio of release (amount of radioactivity released to the
medium) to uptake, and is referred to non-stimulated both control
sc1MVI and knocked down (T-MVI) cells; (b) uptake reﬂects the
amount of radioactivity incorporated into the cells and is a sum of the
radioactivity both released to the medium and remained in the cells
(control, sc1MVI) and (T-MVI). B Distribution of MVI and MV in
PC12 cells before and after 10-min stimulation with 56 mM KCl.
Both myosins (in green) were stained with the respective antibodies
and chromafﬁn granules (red) with anti-dopamine b-hydroxylase
antibody. These are the 0.8 lm images of cell center attained with
Leica TCS SP2 spectral confocal microscope equipped with HCX PL
APO 63x/1.25-0.75 Oil Cs objective. Other details as described under
‘‘Materials and methods’’ section. Bars 10 lm. C Morphology of
unstimulated and 10-min stimulated PC12 cells. Micrographs were
attained with scanning (SEM) and transmission (TEM) electron
microscopes as described under ‘‘Materials and methods’’ section.
Bars 1 lm in SEM and 200 nm in TEM
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123caused by cell cycle arrest in G0/G1 phase and was not
resulting from cell senescence. Yoshida et al. (2004) have
reported, however, that inhibition of MVI expression did
not affect cell proliferation of malignant ovarian cancer
cells. Yet another mechanism of engagement of MVI in the
control of cell proliferation was proposed by Vreugde et al.
(2006) who demonstrated that MVI was involved in the
regulation of gene transcription in human prostate cancer
PC3 cells. The presence of MVI in the nuclei of both PC12
and primary culture bovine adrenal medulla cells seems to
indicate that this mechanism could be also utilized in these
neurosecretory cells (Majewski et al. 2010).
A couple of studies have tied MVI with the secretion
process(Warneretal.2003;Osterweiletal.2005;Yanoetal.
2006). Warner et al. (2003) have shown that ﬁbroblasts
obtained from mice lacking MVI did not only have smaller
(by*40%comparedwithwild-typecells)andalteredGolgi
complexes but also secreted less of a reporter protein, indi-
cating strong relationship between MVI-dependent func-
tional state of Golgi and secretory properties of ﬁbroblasts.
Similar conclusions were reached based on the studies on
hippocampal neurons. Yano et al. (2006) showed that MVI
played important role in neurotransmission as its lack
resulted in 63% decrease of basal synaptic transmission and
abolished the BDNF-induced glutamate release. Herein, we
also observed signiﬁcant changes in Golgi complex mor-
phology in transiently and stably MVI depleted cells.
Therefore, it was surprising that our studies did not reveal
any substantial effect of MVI depletion on noradrenaline
release. Instead of expected inhibition of neurotransmitter
secretion, we obtained statistically insigniﬁcant increase in
the release:uptake ratio in the knockdown cells. This small
enhancement was mostprobablyduetothe increased uptake
of radioactive noradrenaline resulting from signiﬁcant
changesinactincytoskeletonorganizationobservedinMVI-
deﬁcient cells. This observation was also inconsistent with
studies demonstrating that lack of MVI impaired endocyto-
sis-based incorporation of particles (Osterweil et al. 2005;
Ameen and Apodaca 2007; Holt et al. 2007; Gotoh et al.
2010).Noteworthy,weobservedthatstimulation-dependent
translocation of chromafﬁn granules towards cell periphery
was not associated with MVI but with MV, indicating that
MVI might not be directly involved in chromafﬁn granule
translocation.
We think that lack of the evident effect of MVI deple-
tion on noradrenaline secretion could be explained by
(i) the presence of about 20–30% of endogenous protein
in T-MVI cells, which might still compensate for MVI
deﬁcit; (ii) changes in actin cytoskeleton organization in
T-MVI cell, which enabled higher catecholamine uptake
by the modiﬁed cells and/or for more efﬁcient transport by
the actin-based molecular motors such as MV of chro-
mafﬁn granules to the cell periphery; (iii) another, yet
unrecognized, mechanism in PC12 cells of MVI involve-
ment in catecholamine secretion and endocytosis, and
ﬁnally (iv) MVI in PC12 cells is not involved in
neurosecretion.
Summarizing, our studies addressing the role of MVI in
neurosecretory PC12 cells indicate that MVI is involved in
actin cytoskeleton organization, cell migration and prolif-
eration as well as in Golgi maintenance but is not a key
motor in catecholamine secretion.
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